化合物Ridinilazole T16748
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
1 mL | 308362-25-6 | ¥1,420.00 | 询底价 |
1 mg | 308362-25-6 | ¥687.00 | 询底价 |
50 mg | 308362-25-6 | ¥5,630.00 | 询底价 |
5 mg | 308362-25-6 | ¥1,370.00 | 询底价 |
100 mg | 308362-25-6 | ¥7,630.00 | 询底价 |
10 mg | 308362-25-6 | ¥2,320.00 | 询底价 |
25 mg | 308362-25-6 | ¥4,120.00 | 询底价 |
2 mg | 308362-25-6 | ¥923.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Ridinilazole
描述: Ridinilazole (SMT19969) 是一种新型的窄谱非吸收性抗生素。它显示出对艰难梭菌的有效抑制作用 (MIC90=0.125 mg/L),并且比甲硝唑 (MIC90 = 8 mg/L) 或万古霉素 (MIC90 = 2 mg/L) 更有效。
体内活性: ridinilazole , a novel antibacterial currently under development for the treatment of CDI.?Owing to its highly targeted spectrum of activity and ability to spare the normal gut microbiota, ridinilazole provides significant advantages over metronidazole and vancomycin, the mainstay antibiotics for CDI.?Ridinilazole is bactericidal against C. difficile and exhibits a prolonged post-antibiotic effect.?Furthermore, treatment with ridinilazole results in decreased toxin production.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 55 mg/mL (141.6 mM)
关键字: inhibit | Bacterial | SMT-19969 | Ridinilazole | SMT 19969 | Inhibitor
相关产品: Coixol | Perillene | Nifuratel | Chebulinic acid | CHEMBL1380345 | Lasalocid | Rhapontigenin | Lawsone methyl ether | Aloin(mixture of A&B) | CysHHC10 acetate
相关库: Drug Repurposing Compound Library | Antibiotics Library | Drug-induced Liver Injury (DILI) Compound Library | Clinical Compound Library | Bioactive Compounds Library Max | Pediatric Drug Library | Anti-Bacterial Compound Library | NO PAINS Compound Library | Anti-Infection Compound Library | Bioactive Compound Library
化合物Ridinilazole T16748信息由TargetMol中国为您提供,如您想了解更多关于化合物Ridinilazole T16748报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途